Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Business Watch.
Press releases published on May 9, 2025
Okeanis Eco Tankers Corp. – Invitation to Q1 2025 Results Conference Call and Webcast
GlobeNewswire
·
May 9, 2025
ATHENS, Greece, May 09, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), will report unaudited condensed results for the first quarter of 2025, after market close on the NYSE, on Wednesday, May 14, 2025, and …
NI Holdings, Inc. Reports Results for First Quarter Ended March 31, 2025
GlobeNewswire
·
May 9, 2025
FARGO, N.D., May 09, 2025 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (NASDAQ: NODK) announced today results for the quarter ended March 31, 2025. Summary of First Quarter 2025 Results – Continuing Operations (All comparisons vs. continuing operations for the …
Motorsport Games Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “the Company”) today reported financial results for its first quarter ended March 31, 2025. The Company has also posted the first quarter 2025 earnings …
Instrak Venture Capital Berhad Announces Strategic Intent to Invest in GA Skylight Berhad
EIN Presswire
·
May 9, 2025
KUALA LUMPUR, MALAYSIA, May 9, 2025 /EINPresswire.com/ -- 8 May 2025 – Instrak Venture Capital Berhad (IVCB) is proud to announce its strategic intent to invest in GA Skylight Berhad (GA Skylight), signifying the start of a transformative partnership set …
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 9, 2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration …
Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment
GlobeNewswire
·
May 9, 2025
- Stenoparib continues to demonstrate clinical benefit in heavily pre-treated ovarian cancer, with two patients remaining on treatment for more than 19 months - Initiated utilization of share repurchase program - Cash and restricted cash balance …
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire
·
May 9, 2025
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, …
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee …
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
PRINCETON, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 9, 2025
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended March 31, 2025. “ …
Navigator Gas Announces Change to Board of Directors
GlobeNewswire
·
May 9, 2025
LONDON, May 09, 2025 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces the following change to …
Tyson Foods Announces Quarterly Dividend
GlobeNewswire
·
May 9, 2025
SPRINGDALE, Ark., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Tyson Foods (NYSE: TSN), at a meeting on May 8, 2025, declared a quarterly dividend of $0.50 per share on Class A common stock and $0.45 per share on Class B common stock, payable …
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
GlobeNewswire
·
May 9, 2025
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25 On-track to enable dosing ALS patients in late 2025 BOTHELL, Wash., May 09, 2025 ( …
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2025
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 30, 2025, short interest in 3,156 Nasdaq Global MarketSM securities totaled 13,300,707,903 shares compared with 13,211,633,004 shares in 3,143 Global Market issues …
Matador Technologies Inc. Announces Non-Brokered Private Placement
GlobeNewswire
·
May 9, 2025
TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF), a Bitcoin-focused technology and investment company, is pleased to announce a non-brokered private placement offering of up to 5, …
Parks! America, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 9, 2025
Management to host conference call on Monday, May 12, 2025, at 4:30 PM ET PINE MOUNTAIN, Georgia, May 09, 2025 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCQX: PRKAD), today announced its financial results for the second fiscal quarter ended March 30, 2025 …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 5, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 111,750 shares of …
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
GlobeNewswire
·
May 9, 2025
CARLSBAD, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has completed the sale of an additional 502,500 shares of its common stock at a public offering price …
Orange Bank & Trust Expands Commitment to Construction and Trade Industries
GlobeNewswire
·
May 9, 2025
MIDDLETOWN, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Orange Bank …